[Retracted] miR‑338‑3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2
- PMID: 34195848
- PMCID: PMC8253587
- DOI: 10.3892/ijo.2021.5237
[Retracted] miR‑338‑3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2
Abstract
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the western blotting data shown in Fig. 5C and D bore unexpected similarities to data appearing in different form in other articles by different authors. Owing to the fact that some of the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Internatiοnal Journal of Oncology, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in International Journal of Oncology 46: 2277‑2285, 2015; DOI: 10.3892/ijo.2015.2929].
Keywords: PI3K/AKT pathway; Runx2; miR-338-3p; ovarian cancer; ovarian epithelial carcinoma.
Retraction of
-
miR‑338‑3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2.Int J Oncol. 2015 May;46(5):2277-85. doi: 10.3892/ijo.2015.2929. Epub 2015 Mar 16. Int J Oncol. 2015. Retraction in: Int J Oncol. 2021 Aug;59(2):57. doi: 10.3892/ijo.2021.5237. PMID: 25776272 Retracted.
Publication types
LinkOut - more resources
Full Text Sources